Zhejiang Jingxin Pharmaceutical Co.,Ltd.’s Net Profit Rose 3.1% in First Quarter of 2022

Zhejiang Jingxin Pharmaceutical Co.,Ltd. (浙江京新药业股份有限公司) (002020.SZ) reported a net profit of 137.9 million yuan in the first quarter of 2022, up 3.1% year-on-year.

Meanwhile, the company posted 870.6 million yuan in revenue, up 1.5% year-on-year.

At the end of the reporting period, it had 6.6 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 25.3%.